United Therapeutics Corp. (UTHR) PT Lowered to $103 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
United Therapeutics Corp. (UTHR) PT Lowered to $107 at Ladenburg Thalmann
May 3, 2018 6:56 AM EDTLadenburg Thalmann lowered its price target on United Therapeutics Corp. (NASDAQ: UTHR) to $107.00 (from $120.00) while maintaining a Neutral rating.
... MoreUnited Therapeutics Corp. (UTHR) PT Lowered to $95 at Barclays
May 3, 2018 3:55 AM EDTBarclays lowered its price target on United Therapeutics Corp. (NASDAQ: UTHR) to $95.00 (from $105.00) while maintaining a Underweight rating.
... MoreJMP Securities Downgrades SteadyMed (STDY) to Market Perform Following Acquisition
May 1, 2018 3:25 AM EDTJMP Securities downgraded SteadyMed (NASDAQ: STDY) from Market Outperform to Market Perform.
Analyst Donald Ellis steps to the sideline following the recent acquisition by United Therapeutics (NASDAQ: UTHR). The analyst is not expecting a competing offer to... More
